Stories about research and scientific development at Mount Sinai
Tracking SARS-CoV-2 and its Evolving Variants
A new variant of SARS-CoV-2, the virus that causes COVID-19, appeared in Great Britain in greater frequency in December and has been reported in New York State. The new variant appears to spread more rapidly than older ones and has a distinct set of...
Why Testing New Medicines in a Diverse Population Is Important
Companies are working to develop new vaccines for COVID-19, and one of the many challenges is ensuring that clinical trials required to test the new medicines reflect the population at large in order to determine how effective the vaccines will be when...
mRNA Vaccine Technology Makes Its Extraordinary Debut
The mRNA technology used to create the first two COVID-19 vaccines from Pfizer Inc., and Moderna, Inc. will undoubtedly change the course of vaccine development for years to come.Both companies have “shown that the vaccines are extraordinary,” says Peter...
Mount Sinai Researchers Use Apple Watch to Predict COVID-19
Subtle changes in an individual’s heartbeat, which can be measured on an Apple Watch, are able to signal the onset of COVID-19 up to seven days before individuals are diagnosed with the infection. That preliminary observation was made by...
Esteemed Vaccinologist Weighs in on New Vaccines and the ‘Beginning of the End of the Pandemic’
“Dear world, we have a vaccine!”Florian Krammer, PhD, Professor of Vaccinology at the Icahn School of Medicine at Mount Sinai recently tweeted this in response to news of the interim results to Pfizer Inc.’s COVID-19 vaccine clinical trial, which showed...
New England Journal of Medicine Study of Marine Recruits Provides Lessons in Controlling the Spread of COVID-19
To effectively control the spread of SARS-CoV-2, the virus that causes COVID-19, public health measures such as wearing face masks, social distancing, and handwashing must be combined with repeated and widespread testing. That is the conclusion of a new study in The...
Overwhelming Majority of People Mount a Strong Immune Response to COVID-19: A Good Sign for Future Vaccines
More than 90 percent of people who recovered at home from mild and moderate cases of COVID-19 produced a robust and possibly protective level of antibodies that remained relatively stable for at least five months, according to a new study by researchers at the Icahn...
Mount Sinai Physicians Create an Effective Road Map for Treating COVID-19
Experts at the Mount Sinai Health System have created a road map for clinicians to follow when providing care to COVID-19 patients, which characterizes four distinct stages of the COVID-19 disease cycle and outlines specific testing and...
Mount Sinai Researchers Streamline Patient Data to Find Patterns in COVID-19 Patients
With the influx of patient data resulting from the SARS-CoV-2 pandemic, the Mount Sinai COVID Informatics Center is collaborating with London-based software company Clinithink to uncover key findings that can enable better treatment methods for...